EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis

David B Clifford, Beau Ances, Craig Costello, Shari Rosen-Schmidt, Magnus Andersson, Deborah Parks, Arie Perry, Raju Yerra, Robert Schmidt, Enrique Alvarez, Kenneth L Tyler

Archives of Neurology · 01.09.2011 · 68 (9) · 1156

DOI: 10.1001/archneurol.2011.103 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Neurology, erschienen am 01.09.2011. Verfasst von David B Clifford und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University, St Louis, MO 63110, USA. cliffordd@neuro.wustl.edu. Die Arbeit wurde bisher 239-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINR NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe the development of progressive multifocal leukoencephalopathy (PML) in patients with rheumatoid arthritis (RA) treated with rituximab.

Design

Case study.

Setting

Clinical care for patients with rheumatologic diseases. Most were referred to academic centers for care after diagnosis (Washington University, St Louis, Missouri; Karolinska Insitute, Stockholm, Sweden; and Royal Melbourne Hospital, Melbourne, Australia) while one was cared for in a neurology practice in Dallas, Texas, with consultation by an academic neurovirologist from the University of Colorado in Denver. Patients Four patients developing PML in the setting of rituximab therapy for RA.

Intervention

Rituximab therapy. Main Outcome Measures Clinical and pathological observations.

Results

Four patients from an estimated population of 129 000 exposed to rituximab therapy for RA are reported in whom PML developed after administration of this drug. All were women older than 50 years, commonly with Sjögren syndrome and a history of treatment for joint disease ranging from 3 to 14 years. One case had no prior biologic and minimal immunosuppressive therapy. Progressive multifocal leukoencephalopathy presented as a progressive neurological disorder, with diagnosis confirmed by detection of JC virus DNA in the cerebrospinal fluid or brain biopsy specimen. Two patients died in less than 1 year from PML diagnosis, while 2 remain alive after treatment withdrawal. Magnetic resonance scans and tissue evaluation confirmed the frequent development of inflammatory PML during the course of the disease.

Conclusion

These cases suggest an increased risk, about 1 case per 25 000 individuals, of PML in patients with RA being treated with rituximab. Inflammatory PML may occur in this setting even while CD20 counts remain low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAntibodies, Monoclonal, Murine-DerivedArthritis, RheumatoidFemaleHumansLeukoencephalopathy, Progressive MultifocalMiddle AgedRituximab

Substanzen

Antibodies, Monoclonal, Murine-DerivedRituximab

Autor:innen und Institutionen

  • Department of Neurology, Washington University, St Louis, MO 63110, USA. cliffordd@neuro.wustl.edu

Förderung

  • NIA NIH HHS
  • NINR NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Clifford, D. B., Ances, B., Costello, C., Rosen-Schmidt, S., Andersson, M., Parks, D., Perry, A., Yerra, R., Schmidt, R., Alvarez, E., & Tyler, K. L. (2011). Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis. Archives of Neurology, 68(9), 1156. https://doi.org/10.1001/archneurol.2011.103

Vancouver

Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, et al. Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis. Archives of Neurology. 2011;68(9):1156. doi:10.1001/archneurol.2011.103

BibTeX
@article{Clifford2011,
  author = {Clifford, David B and Ances, Beau and Costello, Craig and Rosen-Schmidt, Shari and Andersson, Magnus and Parks, Deborah and Perry, Arie and Yerra, Raju and Schmidt, Robert and Alvarez, Enrique and Tyler, Kenneth L},
  title = {Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis},
  journal = {Archives of Neurology},
  year = {2011},
  volume = {68},
  number = {9},
  pages = {1156},
  doi = {10.1001/archneurol.2011.103}
}
Kostenlos starten →